EASDAQ's niche may be appearing

OXFORD - European bioscience companies looking to make public offerings are favoring their home stock exchanges if a robust market exists, otherwise the trend may be to choose EASDAQ.

Pharming Group N.V. (Leiden, the Netherlands) has unveiled its intention to float on EASDAQ, while last Friday Chemunex S.A. (EASDAQ:CHMX; Paris, France) became the first company to have its shares listed on both EASDAQ and Le Nouveau Marche, the Paris Bourse's market for high growth companies that was set up as a competitor to EASDAQ...